Ubs Asset Management Americas Inc Inovio Pharmaceuticals, Inc. Transaction History

Ubs Asset Management Americas Inc

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$1.41 - $2.5 $23,500 - $41,667	-16,667 Reduced 9.92%	151,318 $236,000
Q3 2022 Nov 14, 2022	SELL	$1.66 - $2.79 $74,741 - $125,619	-45,025 Reduced 21.14%	167,985 $290,000
Q2 2022 Aug 12, 2022	BUY	$1.44 - $3.98 $71,894 - $198,709	49,927 Added 30.61%	213,010 $368,000
Q4 2021 Feb 14, 2022	BUY	$4.99 - $7.46 $29,915 - $44,722	5,995 Added 3.82%	163,083 $813,000
Q3 2021 Nov 15, 2021	SELL	$7.16 - $9.69 $13,102 - $17,732	-1,830 Reduced 1.15%	157,088 $1.12 Million
Q2 2021 Aug 16, 2021	SELL	$6.23 - $10.03 $97,150 - $156,407	-15,594 Reduced 8.94%	158,918 $1.47 Million
Q1 2021 May 14, 2021	SELL	$8.81 - $16.96 $171,865 - $330,855	-19,508 Reduced 10.05%	174,512 $1.62 Million
Q4 2020 Mar 01, 2021	BUY	$8.5 - $12.85 $25,721 - $38,884	3,026 Added 1.58%	194,020 $1.72 Million
Q3 2020 Nov 13, 2020	BUY	$9.57 - $27.05 $432,784 - $1.22 Million	45,223 Added 31.02%	190,994 $2.22 Million
Q2 2020 Aug 14, 2020	BUY	$7.14 - $31.69 $1.04 Million - $4.62 Million	145,771 New	145,771 $3.93 Million
Q4 2019 Feb 14, 2020	SELL	$1.97 - $3.72 $161,224 - $304,444	-81,840 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$2.05 - $3.02 $16,611 - $24,471	8,103 Added 10.99%	81,840 $167,000
Q1 2019 May 14, 2019	BUY	$3.34 - $5.1 $34,378 - $52,494	10,293 Added 16.22%	73,737 $0
Q2 2018 Aug 14, 2018	BUY	$3.88 - $5.16 $93,476 - $124,314	24,092 Added 61.22%	63,444 $0
Q1 2018 May 14, 2018	BUY	$4.05 - $5.69 $51,912 - $72,934	12,818 Added 48.31%	39,352 $0
Q3 2017 Nov 13, 2017	BUY	$5.36 - $6.37 $142,222 - $169,021	26,534	26,534 $0

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $519M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

Stay updated on Ubs Asset Management Americas Inc with notifications on news.